SIGNIFICANCE OF A PARTIAL OR SLOW RESPONSE TO FRONT-LINE CHEMOTHERAPY IN THE MANAGEMENT OF INTERMEDIATE-GRADE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA - A LITERATURE-REVIEW

被引：43
|
作者：
HAQ, R
SAWKA, CA
FRANSSEN, E
BERINSTEIN, NL
机构：
[1] TORONTO BAYVIEW REG CANC CTR,DEPT MED,TORONTO M4N 3M5,ON,CANADA
[2] TORONTO BAYVIEW REG CANC CTR,DEPT CLIN TRIALS & EPIDEMIOL,TORONTO M4N 3M5,ON,CANADA
[3] TORONTO BAYVIEW REG CANC CTR,DEPT IMMUNOL,TORONTO M4N 3M5,ON,CANADA
[4] SUNNYBROOK HLTH SCI CTR,TORONTO M4N 3M5,ON,CANADA
[5] UNIV TORONTO,TORONTO,ON,CANADA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1994年 / 12卷 / 05期
关键词：
D O I：
10.1200/JCO.1994.12.5.1074
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1074 / 1084
页数：11
相关论文
共 50 条
  • [31] A 6-DRUG REGIMEN (MAPECO) FOR INTERMEDIATE OR HIGH-GRADE NON-HODGKINS-LYMPHOMA
    PENDLETON, N
    GREEN, JA
    ACTA ONCOLOGICA, 1994, 33 (05) : 513 - 518
  • [32] A CRITICAL ANALYSIS OF PROGNOSTIC FACTORS FOR SURVIVAL IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA
    HAYWARD, RL
    LEONARD, RCF
    PRESCOTT, RJ
    BRITISH JOURNAL OF CANCER, 1991, 63 (06) : 945 - 952
  • [33] RESIDUAL ABDOMINAL MASSES FOLLOWING INTENSIVE WEEKLY CHEMOTHERAPY FOR INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA (NHL)
    SWEETENHAM, JW
    MEAD, GM
    WHITEHOUSE, JMA
    BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 525 - 525
  • [34] M-BACOD CHEMOTHERAPY IN ADVANCED, HIGH-GRADE, MALIGNANT NON-HODGKINS-LYMPHOMA
    NEUMANN, E
    GEISSLER, K
    BLUT, 1986, 53 (03): : 142 - 142
  • [35] CHEMOTHERAPY OF INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS LYMPHOMAS WITH A HIGH-DOSE DOXORUBICIN-CONTAINING REGIMEN
    ZUCKERMAN, KS
    LOBUGLIO, AF
    REEVES, JA
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (02) : 248 - 256
  • [36] MOLECULAR GENETIC-ANALYSIS OF HIGH-GRADE NON-HODGKINS-LYMPHOMA AND HODGKINS LYMPHOMA
    KNEBA, M
    BOLZ, I
    BERGHOLZ, M
    NAGEL, GA
    KRONKE, M
    KRIEGER, G
    BLUT, 1987, 55 (04): : 244 - 244
  • [37] SIGNIFICANCE OF HIGH-DOSE THERAPY IN THE TREATMENT OF HIGH-GRADE MALIGNANT NON-HODGKINS-LYMPHOMA
    GOLDSTONE, AH
    ONKOLOGIE, 1995, 18 (01): : 78 - 79
  • [38] STAGING AND TREATMENT OF NON-HODGKINS-LYMPHOMA OF INTERMEDIATE-GRADE MALIGNANCY - A RETROSPECTIVE STUDY OF 102 CASES
    SCHAAFSMA, MR
    BIEGER, R
    HERMANS, J
    KLUIN, PM
    NOORDIJK, EM
    WILLEMZE, ER
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 39 (03) : 252 - 258
  • [39] RANDOMIZED COMPARISON OF MACOP-B WITH CHOP IN PATIENTS WITH INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMA
    COOPER, IA
    WOLF, MM
    ROBERTSON, TI
    FOX, RM
    MATTHEWS, JP
    STONE, JM
    DING, JC
    DART, G
    MATTHEWS, J
    FIRKIN, FC
    LOWENTHAL, RM
    IRONSIDE, P
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) : 769 - 778
  • [40] CHEMOTHERAPY OF INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS
    CONSTANTOULAKIS, M
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 659 - 661
12345